Skip to content

Study on the Dose-Effect Relationship of Ginger-Partitioned Moxibustion in the Treatment of Allergic Rhinitis

Study on the Dose-Effect Relationship of Ginger-Partitioned Moxibustion in the Treatment of Allergic Rhinitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005231
Enrollment
Unknown
Registered
2021-08-26
Start date
2021-09-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Sponsors

Shanghai TCM-Integrated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Men or women aged 18 to 60 years; 2. Those who have perennial allergic rhinitis; 3. Those who meet diagnostic criteria of allergic rhinitis; 4. Those who have not used any drugs or treatment methods for allergic rhinitis 2 weeks before the trial; 5. Those who accept ginger moxibustion treatment; 6. Those who are willing to cooperate with this trial treatment plan; 7. Those who are willing to sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to smoke and dust produced by moxibustion; 2. Those who are pregnant, breastfeeding during the study period; 3. Those who have serious disease related to the blood vessel, liver, kidney or haematopoietic system; 4. Those who have mental illness; 5. Those who are complicated with rhinosinusitis, otitis media, nasal polyps, nasal septum deviation and other ENT infections or organic lesions; 6. Those who have asthma and other paroxysmal respiratory diseases and are in the attack period; 7. Those who are participating in the other clinical trials of moxibustion.

Design outcomes

Primary

MeasureTime frame
Total Nasal Symptom Score (TNSS);

Secondary

MeasureTime frame
Rhino Conjunctivitis Quality of Life Questionnaire (RQLQ);

Countries

China

Contacts

Public ContactWang Wen

Shanghai TCM-Integrated Hospital

wendywang_8@163.com+86 15021839823

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026